Selarsdi - NDC Database
3 records found
Page:
51759-505 Mar 12, 2025
Selarsdi 45 mg/.5ml Subcutaneous Injection, Solution by Teva Pharmaceuticals USA, Inc.
Selarsdi 45 mg/.5ml Subcutaneous Injection, Solution by Teva Pharmaceuticals USA, Inc.
51759-607 Mar 12, 2025
Selarsdi 90 mg/ml Subcutaneous Injection, Solution by Teva Pharmaceuticals USA, Inc.
Selarsdi 90 mg/ml Subcutaneous Injection, Solution by Teva Pharmaceuticals USA, Inc.
51759-708 Mar 12, 2025
Selarsdi 130 mg/26ml Intravenous Injection, Solution by Teva Pharmaceuticals USA, Inc.
Selarsdi 130 mg/26ml Intravenous Injection, Solution by Teva Pharmaceuticals USA, Inc.
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.